Fast monolith-based chromatographic method for determination of methotrexate in drug delivery studies

Rapid and sustainable HPLC method for the determination of uremic toxins in human plasma samples

Protein-bound uremic toxins, mainly indoxyl sulfate (3-INDS), p-cresol sulfate (pCS), and indole-3-acetic acid (3-IAA) but also phenol (Pol) and p-cresol (pC), are progressively accumulated during chronic kidney disease (CKD). Their accurate measurement in biomatrices is demanded for timely diagnosis and adoption of appropriate therapeutic measures. Multianalyte methods allowing the establishment of a uremic metabolite profile are still missing. Hence, the aim of this work was to develop a rapid and sensitive method based on high-performance liquid chromatography with fluorescence detection for the simultaneous quantification of Pol, 3-IAA, pC, 3-INDS, and pCS in human plasma. Separation was attained in 12 min, using a monolithic C18 column and isocratic elution with acetonitrile and phosphate buffer containing an ion-pairing reagent, at a flow rate of 2 mL min^-1. Standards were prepared in plasma and quantification was performed using the background subtraction approach. LOQ values were ≤ 0.2 µg mL^-1 for all analytes except for pCS (LOQ of 2 µg mL^-1). The method proved to be accurate (93.5-112%) and precise (CV ≤ 14.3%). The multianalyte application of the method, associated to a reduced sample volume (50 µL), a less toxic internal standard (eugenol) in comparison to the previously applied 2,6-dimethylphenol and 4-ethylphenol, and a green extraction solvent (ethanol), resulted in the AGREE score of 0.62 which is in line with the recent trend of green and sustainable analytical chemistry. The validated method was successfully applied to the analysis of plasma samples from control subjects exhibiting normal levels of uremic toxins and CKD patients presenting significantly higher levels of 3-IAA, pC, 3-INDS, and pCS that can be further investigated as biomarkers of disease progression.

Insights on Ultrafiltration-Based Separation for the Purification and Quantification of Methotrexate in Nanocarriers

The evaluation of encapsulation efficiency is a regulatory requirement for the characterization of drug delivery systems. However, the difficulties in efficiently separating nanomedicines from the free drug may compromise the achievement of accurate determinations. Herein, ultrafiltration was exploited as a separative strategy towards the evaluation of methotrexate (MTX) encapsulation efficiency in nanostructured lipid carriers and polymeric nanoparticles. The effect of experimental conditions such as pH and the amount of surfactant present in the ultrafiltration media was addressed aiming at the selection of suitable conditions for the effective purification of nanocarriers. MTX-loaded nanoparticles were then submitted to ultrafiltration and the portions remaining in the upper compartment of the filtering device and in the ultrafiltrate were collected and analyzed by HPLC-UV using a reversed-phase (C18) monolithic column. A short centrifugation time (5 min) was suitable for establishing the amount of encapsulated MTX in nanostructured lipid carriers, based on the assumption that the free MTX concentration was the same in the upper compartment and in the ultrafiltrate. The defined conditions allowed the efficient separation of nanocarriers from the free drug, with recoveries of >85% even when nanoparticles were present in cell culture media and in pig skin surrogate from permeation assays.

A novel three-dimensional network of CuCr2O4/CuO nanofibers for voltammetric determination of anticancer drug methotrexate

Considering the importance of measuring anticancer drugs, a carbon paste electrode (CPE) modified with CuCr₂O₄/CuO nanofibers in the presence of hydrophobic ionic liquid (IL) was fabricated for methotrexate (MTX) sensing. CuCr₂O₄/CuO nanofibers were prepared by electrospinning method. Then, the morphology and structure of the nanofibers were studied by scanning electron microscopy, thermal analysis, X-ray diffraction, energy-dispersive X-ray, map analysis, and FT-IR spectroscopy. The electrochemical behavior of MTX at CuCr₂O₄/CuO/IL/CPE surface was studied using cyclic voltammetry, differential pulse voltammetry, and electrochemical impedance spectroscopy. After optimization of the experimental parameters, the prepared sensor showed a low detection limit of 25 nM MTX, based on signal-to-noise (S/N = 3), and it can determine in a wide range of 0.1-300 μM in Britton-Robinson buffer solution at pH 2.5. The modified electrode was used to determine MTX concentration in blood and urine samples with good recoveries of 94.1-104.3. This sensor has several advantages such as low cost, easy preparation, high-performance speed and high sensitivity, selectivity, stability, and repeatability. Graphical abstract Scheme of preparation of CuCr₂O₄/CuO nanofibers by electrospinning method and design of a carbon past electrode using prepared nanofibers (CuCr₂O₄/CuO/IL/CPE). This electrode was used for methotrexate determination in plasma and urine samples using differential pulse voltammetry.